Kingsview Wealth Management LLC Has $3.28 Million Stake in Colgate-Palmolive (NYSE:CL)

Kingsview Wealth Management LLC boosted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 133.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,120 shares of the company's stock after buying an additional 20,676 shares during the period. Kingsview Wealth Management LLC's holdings in Colgate-Palmolive were worth $3,284,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $32,000. Hager Investment Management Services LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the third quarter valued at $53,000. Finally, Synergy Asset Management LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $49,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CL shares. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, January 8th. Finally, Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $101.16.

Colgate-Palmolive Stock Up 1.3 %

NYSE:CL traded up $1.14 on Thursday, hitting $87.87. 3,712,679 shares of the company's stock traded hands, compared to its average volume of 5,028,078. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $82.83 and a 1 year high of $109.30. The firm has a 50-day moving average price of $89.83 and a 200-day moving average price of $96.54. The company has a market cap of $71.79 billion, a PE ratio of 24.96, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 EPS. Equities analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive's dividend payout ratio is 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.